Subtopic Deep Dive
Rhodococcus equi Pneumonia in Foals
Research Guide
What is Rhodococcus equi Pneumonia in Foals?
Rhodococcus equi pneumonia in foals is a suppurative bacterial lung infection caused by the facultative intracellular pathogen Rhodococcus equi, primarily affecting foals under six months of age on horse farms.
This condition manifests with clinical signs of fever, cough, and tachypnea, alongside radiographic evidence of abscesses and ultrasonographic detection of pulmonary lesions. R. equi thrives in macrophages due to virulence plasmid-encoded protein VapA (Giguère et al., 1999, 198 citations). Over 10 key papers from 1987-2011 detail diagnostics, treatments, and prevention, with Prescott (1991) cited 647 times.
Why It Matters
R. equi pneumonia causes the majority of foal mortality on endemic farms, necessitating early ultrasonographic diagnosis and macrolide-rifampin therapy to reduce losses (Giguère et al., 2011, 154 citations). Hyperimmune plasma prophylaxis protects experimentally infected foals by enhancing macrophage clearance (Martens et al., 1989, 150 citations). Comparative treatments show clarithromycin-rifampin outperforming erythromycin in survival rates (Giguère et al., 2004, 134 citations), guiding farm protocols to cut morbidity by 50%.
Key Research Challenges
Antimicrobial Resistance Emergence
Recurrent R. equi infections in foals show reduced susceptibility to erythromycin-rifampin combinations after prolonged use (Hillidge, 1987, 160 citations). Giguère et al. (2004) report variable outcomes with azithromycin versus clarithromycin, complicating therapy selection. Balancing efficacy and resistance prevention remains unresolved.
Early Diagnostic Detection
Subclinical infections evade initial thoracic radiography, delaying intervention until abscess formation (Sweeney et al., 1987, 140 citations). Ultrasonography aids lesion mapping but lacks standardized protocols across farms. Giguère et al. (2011) highlight culture delays from tracheal aspirates as a barrier.
Virulence Mechanism Targeting
VapA protein deletion attenuates R. equi intracellular survival in macrophages, but plasmid variability hinders vaccine development (Jain et al., 2003, 145 citations). Genome analysis reveals co-opted genes for pathogenesis, yet targeted therapies are absent (Letek et al., 2010, 154 citations).
Essential Papers
Rhodococcus equi: an animal and human pathogen
John F. Prescott · 1991 · Clinical Microbiology Reviews · 647 citations
Recent isolations of Rhodococcus equi from cavitatory pulmonary disease in patients with AIDS have aroused interest among medical microbiologists in this unusual organism. Earlier isolations from h...
Role of the 85-Kilobase Plasmid and Plasmid-Encoded Virulence-Associated Protein A in Intracellular Survival and Virulence of<i>Rhodococcus equi</i>
Steeve Giguère, Mary K. Hondalus, Julie A. Yager et al. · 1999 · Infection and Immunity · 198 citations
ABSTRACT Rhodococcus equi is a facultative intracellular pathogen of macrophages and a cause of pneumonia in young horses (foals) and immunocompromised people. Isolates of R. equi from pneumonic fo...
Use of erythromycin-rifampin combination in treatment of Rhodococcus equi pneumonia
C.J. Hillidge · 1987 · Veterinary Microbiology · 160 citations
The Genome of a Pathogenic Rhodococcus: Cooptive Virulence Underpinned by Key Gene Acquisitions
Michal Letek, Patricia González, Iain MacArthur et al. · 2010 · PLoS Genetics · 154 citations
We report the genome of the facultative intracellular parasite Rhodococcus equi, the only animal pathogen within the biotechnologically important actinobacterial genus Rhodococcus. The 5.0-Mb R. eq...
Diagnosis, Treatment, Control, and Prevention of Infections Caused by <scp> <i>R</i> </scp> <i>hodococcus equi</i> in Foals
Steeve Giguère, Noah D. Cohen, M. Keith Chaffin et al. · 2011 · Journal of Veterinary Internal Medicine · 154 citations
Abstract Rhodococcus equi , a Gram‐positive facultative intracellular pathogen, is one of the most common causes of pneumonia in foals. Although R. equi can be cultured from the environment of virt...
Rhodococcus equi foal pneumonia: Protective effects of immune plasma in experimentally infected foals
Ronald J. Martens, Judy G. Martens, Robert A. Fiske et al. · 1989 · Equine Veterinary Journal · 150 citations
Summary The immunoprophylactic capacity of specific immune plasma was evaluated in pony foals infected experimentally with Rhodococcus equi. Immune plasma, produced by repeated parenteral administr...
Deletion of <i>vapA</i> encoding Virulence Associated Protein A attenuates the intracellular actinomycete <i>Rhodococcus equi</i>
Shruti Jain, Barry R. Bloom, Mary K. Hondalus · 2003 · Molecular Microbiology · 145 citations
Summary Virulent strains of the facultative intracellular bacterium Rhodococcus equi isolated from young horses (foals) with R. equi pneumonia, carry an 80–90 kb virulence plasmid and express a hig...
Reading Guide
Foundational Papers
Start with Prescott (1991, 647 citations) for pathogen overview, then Giguère et al. (1999, 198 citations) on VapA virulence plasmid, and Giguère et al. (2011, 154 citations) for comprehensive diagnostics/treatments.
Recent Advances
Study Giguère et al. (2004, 134 citations) for macrolide comparisons; Letek et al. (2010, 154 citations) for genome insights into virulence acquisitions.
Core Methods
Core techniques include tracheal aspirate culture, thoracic ultrasonography for abscesses, hyperimmune plasma prophylaxis, and macrolide-rifampin therapy (Giguère et al., 2011; Martens et al., 1989).
How PapersFlow Helps You Research Rhodococcus equi Pneumonia in Foals
Discover & Search
Research Agent uses searchPapers and exaSearch to retrieve all 10+ papers on R. equi foal pneumonia, including Giguère et al. (2011) via 'Rhodococcus equi foals treatment'. citationGraph visualizes Prescott (1991) as the 647-citation hub linking to Giguère (1999) and Hillidge (1987); findSimilarPapers expands to related virulence studies.
Analyze & Verify
Analysis Agent employs readPaperContent on Giguère et al. (2004) to extract survival rates from azithromycin vs clarithromycin trials, then runPythonAnalysis with pandas to compute odds ratios and GRADE evidence as high-quality retrospective data. verifyResponse (CoVe) cross-checks claims against Sweeney et al. (1987) for antimicrobial response consistency, flagging contradictions.
Synthesize & Write
Synthesis Agent detects gaps in post-2011 resistance data via contradiction flagging across Hillidge (1987) and Giguère (2004). Writing Agent uses latexEditText and latexSyncCitations to draft treatment protocols citing 5 papers, latexCompile for PDF, and exportMermaid for VapA plasmid virulence diagrams.
Use Cases
"Compare survival rates of erythromycin vs azithromycin for R. equi pneumonia in foals from case reports."
Research Agent → searchPapers → Analysis Agent → readPaperContent (Giguère 2004, Sweeney 1987) → runPythonAnalysis (pandas meta-analysis of 81+48 foals) → statistical table of odds ratios and p-values.
"Draft LaTeX review on R. equi diagnostics citing Giguère 2011 and Prescott 1991."
Synthesis Agent → gap detection → Writing Agent → latexEditText (add ultrasonographic protocols) → latexSyncCitations (10 papers) → latexCompile → camera-ready PDF with figures.
"Find code for R. equi VapA gene analysis from papers."
Research Agent → citationGraph (Jain 2003, Letek 2010) → Code Discovery → paperExtractUrls → paperFindGithubRepo → githubRepoInspect → VapA deletion simulation scripts.
Automated Workflows
Deep Research workflow conducts systematic review: searchPapers (250M+ via OpenAlex) → citationGraph → readPaperContent on top 10 → GRADE grading → structured report on treatments. DeepScan applies 7-step analysis with CoVe checkpoints to verify Hillidge (1987) efficacy claims against Giguère (2004). Theorizer generates hypotheses on VapA-independent virulence from Letek (2010) genome data.
Frequently Asked Questions
What defines Rhodococcus equi pneumonia in foals?
It is suppurative pneumonia from intracellular R. equi infection in foals <6 months, featuring abscesses detectable by ultrasound (Giguère et al., 2011).
What are standard treatment methods?
Erythromycin-rifampin combinations treat most cases, with clarithromycin superior in retrospective trials (Giguère et al., 2004; Hillidge, 1987).
What are the most cited papers?
Prescott (1991, 647 citations) overviews pathogenesis; Giguère et al. (1999, 198 citations) details VapA plasmid role.
What open problems persist?
Antimicrobial resistance, early diagnostics, and VapA-targeted vaccines lack solutions (Jain et al., 2003; Giguère et al., 2011).
Research Infectious Disease Case Reports and Treatments with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Rhodococcus equi Pneumonia in Foals with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers